Literature DB >> 18450152

[How infected women in Fortaleza-CE cope with AIDS].

Carolina Maria de Lima Carvalho1, Marli Teresinha Gimeniz Galvão.   

Abstract

The objective of this study was to learn how women with Aids cope with daily living after receiving their diagnosis. It is an exploratory, descriptive study with a qualitative approach based on thematic oral history for data collection and analysis. Ten women with Aids were interviewed at a reference hospital in Fortaleza, State of Ceará, from December 2004 to March 2005. A semi-structured questionnaire was used for data collection. The results revealed different ways of coping, related to the fragility of the discovery of the diagnosis, to the need to hide the infection due to the discrimination and prejudice faced by the victims, and to the constant perception of death. In addition, the women expressed feelings such as shame, concern about family, abandonment, solitude, sadness, fear and anxiety. The authors conclude that, two decades after the epidemic broke out, women still face evident difficulties when they experience their infection.

Entities:  

Mesh:

Year:  2008        PMID: 18450152     DOI: 10.1590/s0080-62342008000100012

Source DB:  PubMed          Journal:  Rev Esc Enferm USP        ISSN: 0080-6234            Impact factor:   1.086


  2 in total

Review 1.  Challenges to an effective response for addressing stigma and discrimination related to HIV: from denial of rights to construction of support networks.

Authors:  Renata Karina Reis; Marli Teresinha Gimeniz Galvão; Elucir Gir
Journal:  J Int AIDS Soc       Date:  2013-12-01       Impact factor: 5.396

2.  Quality of life, socioeconomic and clinical factors, and physical exercise in persons living with HIV/AIDS.

Authors:  Rafaela Catherine da Silva Cunha de Medeiros; Jason Azevedo de Medeiros; Tatiane Andreza Lima da Silva; Ricardo Dias de Andrade; Danielle Coutinho de Medeiros; Juliany de Souza Araújo; Antônio Manuel Gouveia de Oliveira; Marcos Aurélio de Albuquerque Costa; Paulo Moreira Silva Dantas
Journal:  Rev Saude Publica       Date:  2017-07-20       Impact factor: 2.106

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.